Chambers Rebecca

Track

Insider profile

Performance

Overall performance
0.7
Performance over holding periods
0.7
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Chambers Rebecca's trades of Veracyte Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-04 2026-06-04
US Veracyte Inc (VCYT)
PlS Planned sale
54,314 -5.3%
141.82
US$1,635,842 		54,314 -5.3% 141.82 US$1,635,842
2026-06-04 2026-06-04
US Veracyte Inc (VCYT)
PlS Planned sale
74,721 +7.3%
312.19
US$2,552,870 		74,721 +7.3% 312.19 US$2,552,870
2026-06-04 2026-06-04
US Veracyte Inc (VCYT)
PrS Proposed sale
6,885
195.62
US$722,857 		6,885 195.62 US$722,857
2026-03-06 2026-03-04
US Veracyte Inc (VCYT)
PlS Planned sale
13,941 -9.6%
36.33
US$506,460 		13,941 -9.6% 36.33 US$506,460
2026-03-06 2026-03-04
US Veracyte Inc (VCYT)
PlS Planned sale
4,400 -2.9%
35.55
US$156,409 		4,400 -2.9% 35.55 US$156,409
2026-03-04 2026-03-04
US Veracyte Inc (VCYT)
PrS Proposed sale
18,341
35.08
US$643,402 		18,341 35.08 US$643,402
2025-12-04 2025-12-04
US Veracyte Inc (VCYT)
PrS Proposed sale
13,278
47.75
US$634,024 		13,278 47.75 US$634,024
2025-12-04 2025-12-04
US Veracyte Inc (VCYT)
PlS Planned sale
4,741 -4.2%
47.25
US$224,009 		4,741 -4.2% 47.25 US$224,009
2025-12-04 2025-12-04
US Veracyte Inc (VCYT)
PlS Planned sale
8,537 -7.0%
46.61
US$397,946 		8,537 -7.0% 46.61 US$397,946
2025-11-07 2025-11-05
US Veracyte Inc (VCYT)
PlS Planned sale
7,000 -5.3%
41.00
US$287,000 		7,000 -5.3% 41.00 US$287,000
2025-11-05 2025-11-05
US Veracyte Inc (VCYT)
PrS Proposed sale
7,000
36.12
US$252,840 		7,000 36.12 US$252,840
2025-02-05 2025-02-03
US Veracyte Inc (VCYT)
PlS Planned sale
527 -0.5%
43.85
US$23,109 		527 -0.5% 43.85 US$23,109
2024-12-04 2024-12-03
US Veracyte Inc (VCYT)
PlS Planned sale
7,000 -5.8%
43.23
US$302,622 		7,000 -5.8% 43.23 US$302,622
2024-12-03 2024-12-03
US Veracyte Inc (VCYT)
PrS Proposed sale
7,527
44.12
US$332,091 		7,527 44.12 US$332,091
2024-11-14 2024-11-12
US Veracyte Inc (VCYT)
PlS Planned sale
15,275 -10.9%
38.34
US$585,663 		15,275 -10.9% 38.34 US$585,663
2024-11-12 2024-11-12
US Veracyte Inc (VCYT)
PrS Proposed sale
15,275
38.89
US$594,045 		15,275 38.89 US$594,045
2024-06-24 2024-06-21
PlS Planned sale
260 -2.6%
45.99
US$11,957 		260 -2.6% 45.99 US$11,957
2024-05-21 2024-05-20
PlS Planned sale
964 -8.8%
45.39
US$43,756 		964 -8.8% 45.39 US$43,756
2024-05-20 2024-05-20
PrS Proposed sale
1,224
45.75
US$55,998 		1,224 45.75 US$55,998
2021-06-25 2021-06-24
PlS Planned sale
16,727 -55.2%
50.72
US$848,373 		16,727 -55.2% 50.72 US$848,373
2021-05-26 2021-05-25
PlS Planned sale
16,727 -55.2%
45.11
US$754,535 		16,727 -55.2% 45.11 US$754,535
2021-03-29 2021-03-25
PlS Planned sale
13,135 -49.1%
50.16
US$658,903 		13,135 -49.1% 50.16 US$658,903
2021-03-29 2021-03-25
PlS Planned sale
3,592 -11.8%
49.11
US$176,415 		3,592 -11.8% 49.11 US$176,415
2021-03-19 2021-03-18
S Sale
403
2.72
£1,096 		403 2.72 £1,096
2020-09-30 2020-09-30
S Sale
40,000
2.40
£96,000 		40,000 2.40 £96,000